Sign In
Buy CTMX
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
CytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Post Earnings of $0.34 Per Share
11:28pm, Wednesday, 15'th Jul 2020
Wall Street analysts expect CytomX Therapeutics Inc (NASDAQ:CTMX) to announce earnings of $0.34 per share for the current quarter, according to Zacks Investment Research. Four analysts have made estim
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of R, CTMX and JCOM
01:55pm, Wednesday, 15'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 15, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip
Los Angeles, California--(Newsfile Corp. - July 15, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
New York, New York--(Newsfile Corp. - July 14, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cy
Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the Company") (Nasdaq: CTMX) and certain of its officers
New York, New York--(Newsfile Corp. - July 14, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. ("CytomX" or the "Company") (NASDAQ:
Los Angeles, California--(Newsfile Corp. - July 14, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
Edited Transcript of CTMX earnings conference call or presentation 7-May-20 9:00pm GMT
07:49am, Tuesday, 14'th Jul 2020
Q1 2020 CytomX Therapeutics Inc Earnings Call
Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. (
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CONN, CTMX and KL
02:15pm, Monday, 13'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 13, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip
Los Angeles, California--(Newsfile Corp. - July 13, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
SHAREHOLDER ALERT: CTMX JCOM WRCDF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
05:30am, Monday, 13'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 13, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a l
CytomX Investors: Last Days to Seek Participation in Class Action as Lead Plaintiff
03:00pm, Sunday, 12'th Jul 2020
LOS ANGELES, July 12, 2020 -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of CytomX Therapeutics, Inc. investors (NASDAQ:.
New York, New York--(Newsfile Corp. - July 10, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. ("CytomX" or the "Company")(NASDAQ
New York, New York--(Newsfile Corp. - July 10, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
